Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

COVID-19: Which Drug, When, and Why? Monoclonal Antibody Treatments

Source: COVID-19: Which Drug, When, and Why?
Hear expert insights on the role and timing of monoclonal antibody treatments for COVID-19, including specific considerations related to omicron and its subvariants.
Gregory Huhn, MD, MPHTM
Released: April 15, 2022 Expiration: No longer available for credit
Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

This program is supported by an educational grant from
Gilead Sciences, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings